Industry Research Reports

Home > Reports > Service & Software > Global Modified Proteomics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Modified Proteomics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-07-17

Pages: 184 Pages

Report ld: 6977533

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Modified Proteomics Service Market Size(US$)

CAGR 2026-2032

9.2%

Market Size,2032

USD 1,554

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 915 million

Market Forecast in 2032(Value)

US$ 1,554 million

CAGR

9.2%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Modified Proteomics Service market size was US$ 854 million in 2025 and is forecast to reach a readjusted size of US$ 1554 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.

Modified Proteomics Service refers to specialized research services that systematically identify, quantify, localize, and interpret post-translational modifications (PTMs) of proteins using advanced proteomics technologies. Protein post-translational modifications represent chemical alterations occurring after protein synthesis, including phosphorylation, glycosylation, acetylation, ubiquitination, methylation, lipidation, oxidation, and other regulatory modifications. These modifications play critical roles in controlling protein activity, stability, cellular signaling pathways, and disease progression.

Modified proteomics services typically integrate high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS), enrichment strategies, isotope labeling technologies, data-independent acquisition (DIA), advanced bioinformatics, and AI-assisted analytical approaches. Service providers deliver comprehensive solutions covering sample preparation, modification site identification, quantitative analysis, differential modification profiling, pathway interpretation, and biological mechanism discovery.

Compared with conventional proteomics, modified proteomics provides deeper insights into functional changes at the protein level, enabling advanced applications in drug target discovery, disease mechanism investigation, biomarker development, and precision medicine. As pharmaceutical innovation and translational research continue to expand, modified proteomics services have become an essential technology platform supporting modern biomedical research.

The modified proteomics service industry primarily operates under a technology-intensive service model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities. Service providers establish laboratory infrastructure equipped with high-resolution mass spectrometers, nano-flow liquid chromatography systems, automated sample preparation platforms, and computational analysis pipelines. Typical workflows include sample quality assessment, protein extraction, enzymatic digestion, PTM enrichment, LC-MS/MS acquisition, raw data processing, modification site identification, pathway analysis, and scientific report delivery.

From the industry chain perspective, upstream participants include mass spectrometry manufacturers, chromatography suppliers, laboratory consumable providers, biochemical reagent companies, antibody and modified peptide standard suppliers, and computational biology platform providers. The midstream consists of specialized proteomics CRO companies, multi-omics research service providers, and life science technology platforms. Downstream customers include pharmaceutical companies, biotechnology firms, universities, medical institutions, disease research centers, and agricultural biotechnology organizations.

Modified proteomics services generally achieve higher profitability than conventional protein analysis due to their technical complexity and specialized requirements. Advanced services such as phosphoproteomics, ubiquitinomics, glycoproteomics, clinical PTM profiling, and drug mechanism studies typically generate gross margins of approximately 50%-70% due to high technical barriers and complex workflows. Standardized modification analysis services generally achieve margins of around 35%-55% under stronger market competition. Companies with proprietary databases, analytical algorithms, specialized workflows, and pharmaceutical partnerships can achieve margins above 60% through technological differentiation and operational scale.

Modified proteomics services are becoming a rapidly growing segment within precision life science research. As innovative drug development moves beyond genomic information toward functional regulation at the protein level, pharmaceutical companies and research organizations increasingly require detailed insights into dynamic protein changes. Unlike genomics and transcriptomics, modified proteomics directly reveals signaling pathways, disease-related mechanisms, and therapeutic responses through analysis of protein functional states. This creates significant opportunities in oncology, immunotherapy, neurological disorders, metabolic diseases, and targeted drug development. Advances in high-sensitivity mass spectrometry, automated workflows, and AI-driven data interpretation are further expanding the commercial potential of modified proteomics services.

The modified proteomics service industry faces challenges including complex experimental workflows, high analytical costs, sophisticated data interpretation requirements, and limited standardization. Different types of protein modifications exhibit distinct chemical properties, requiring specialized enrichment strategies and analytical methods. In addition, market development may be affected by biotechnology funding cycles, drug development timelines, and research budget fluctuations. Companies need to continuously enhance technology platforms, automation capabilities, databases, and computational solutions to maintain long-term competitiveness.

Future demand for modified proteomics services will increasingly focus on clinical translation, high-throughput profiling, multi-omics integration, and AI-enabled analysis. Pharmaceutical companies will increasingly adopt modified proteomics for mechanism-of-action studies, target validation, and companion diagnostic development to improve R&D efficiency. Biotechnology companies will rely on specialized external services to reduce infrastructure investment and accelerate innovation pipelines. Research institutions and medical organizations will expand applications in disease mechanism studies, early detection, and precision treatment. As life science research becomes increasingly data-driven, service providers with advanced analytical platforms, comprehensive databases, and integrated interpretation capabilities will achieve stronger competitive advantages in the global market.

The global Modified Proteomics Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

PTM BIO
Cell Signaling Technology (CST)
APTBIO
BGI Genomics
OmicScouts (Momentum Biotechnologies)
Biodesix
Shanghai OE Biotech
Crown Bioscience
Shanghai Bioprofile
Creative Proteomics
Inotiv
MtoZ-Biolabs
CellCarta
Biognosys
MS Bioworks
Charles River Laboratories
Metware Biotechnology
Novogene
Evotec
RxCelerate
Shanghai Majorbio Bio-Pharm
Lc-Bio Technologies
CD Genomics
Discovery Life Sciences
Applied Biomics
VProteomics
Allumiqs
Westlake Omics
CDI Labs
Proteome Sciences
Sapient Bioanalytics
Proteomics International
Cosmos Wisdom
MRM Proteomics
Sinotech Genomics
Precision Biomarker Laboratories (PBL)

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Phosphorylation
Acetylation
Ubiquitination
Methylation
Glycosylation
Lactylation
Redox
Palmitoylation
Others

Segment by Application

Clinical Diagnostics
Drug Discovery
Others

Segment by Category

Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others

Segment by Division

Oncology
Cardiovascular
Agriculture
Neuroscience
Other

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Modified Proteomics Service value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Phosphorylation

1.2.3 Acetylation

1.2.4 Ubiquitination

1.2.5 Methylation

1.2.6 Glycosylation

1.2.7 Lactylation

1.2.8 Redox

1.2.9 Palmitoylation

1.2.10 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Clinical Diagnostics

1.3.3 Drug Discovery

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Modified Proteomics Service Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Modified Proteomics Service Market Share by Revenue, by Region (2021-2026)

2.4 Global Modified Proteomics Service Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Modified Proteomics Service Market Size and Prospective (2021-2032)

2.5.2 Europe Modified Proteomics Service Market Size and Prospective (2021-2032)

2.5.3 China Modified Proteomics Service Market Size and Prospective (2021-2032)

2.5.4 Japan Modified Proteomics Service Market Size and Prospective (2021-2032)

2.5.5 Southeast Asia Modified Proteomics Service Market Size and Prospective (2021-2032)

2.5.6 India Modified Proteomics Service Market Size and Prospective (2021-2032)

2.5.7 South America Modified Proteomics Service Market Size and Prospective (2021-2032)

2.5.8 Middle East Modified Proteomics Service Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Modified Proteomics Service Historical Market Size by Type (2021-2026)

3.2 Global Modified Proteomics Service Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Modified Proteomics Service

4 Breakdown Data by Application

4.1 Global Modified Proteomics Service Historical Market Size by Application (2021-2026)

4.2 Global Modified Proteomics Service Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Modified Proteomics Service Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Modified Proteomics Service Players by Revenue (2021-2026)

5.1.2 Global Modified Proteomics Service Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Modified Proteomics Service Revenue

5.4 Global Modified Proteomics Service Market Concentration Analysis

5.4.1 Global Modified Proteomics Service Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Modified Proteomics Service Revenue in 2025

5.5 Global Key Players of Modified Proteomics Service Head Offices and Areas Served

5.6 Global Key Players of Modified Proteomics Service, Product and Application

5.7 Global Key Players of Modified Proteomics Service, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Modified Proteomics Service Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Modified Proteomics Service Market Size by Type (2021-2026)

6.1.2.2 North America Modified Proteomics Service Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Modified Proteomics Service Market Size by Application (2021-2026)

6.1.3.2 North America Modified Proteomics Service Market Share by Application (2021-2026)

6.1.4 North America Modified Proteomics Service Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Modified Proteomics Service Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Modified Proteomics Service Market Size by Type (2021-2026)

6.2.2.2 Europe Modified Proteomics Service Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Modified Proteomics Service Market Size by Application (2021-2026)

6.2.3.2 Europe Modified Proteomics Service Market Share by Application (2021-2026)

6.2.4 Europe Modified Proteomics Service Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Modified Proteomics Service Revenue by Company (2021-2026)

6.3.2 China Market Size by Type

6.3.2.1 China Modified Proteomics Service Market Size by Type (2021-2026)

6.3.2.2 China Modified Proteomics Service Market Share by Type (2021-2026)

6.3.3 China Market Size by Application

6.3.3.1 China Modified Proteomics Service Market Size by Application (2021-2026)

6.3.3.2 China Modified Proteomics Service Market Share by Application (2021-2026)

6.3.4 China Modified Proteomics Service Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Modified Proteomics Service Revenue by Company (2021-2026)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Modified Proteomics Service Market Size by Type (2021-2026)

6.4.2.2 Japan Modified Proteomics Service Market Share by Type (2021-2026)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Modified Proteomics Service Market Size by Application (2021-2026)

6.4.3.2 Japan Modified Proteomics Service Market Share by Application (2021-2026)

6.4.4 Japan Modified Proteomics Service Major Customers

6.4.5 Japan Market Trends and Opportunities

6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers

6.5.1 Southeast Asia Modified Proteomics Service Revenue by Company (2021-2026)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia Modified Proteomics Service Market Size by Type (2021-2026)

6.5.2.2 Southeast Asia Modified Proteomics Service Market Share by Type (2021-2026)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia Modified Proteomics Service Market Size by Application (2021-2026)

6.5.3.2 Southeast Asia Modified Proteomics Service Market Share by Application (2021-2026)

6.5.4 Southeast Asia Modified Proteomics Service Major Customers

6.5.5 Southeast Asia Market Trends and Opportunities

6.6 India Market: Players, Segments, Downstream and Major Customers

6.6.1 India Modified Proteomics Service Revenue by Company (2021-2026)

6.6.2 India Market Size by Type

6.6.2.1 India Modified Proteomics Service Market Size by Type (2021-2026)

6.6.2.2 India Modified Proteomics Service Market Share by Type (2021-2026)

6.6.3 India Market Size by Application

6.6.3.1 India Modified Proteomics Service Market Size by Application (2021-2026)

6.6.3.2 India Modified Proteomics Service Market Share by Application (2021-2026)

6.6.4 India Modified Proteomics Service Major Customers

6.6.5 India Market Trends and Opportunities

7 Key Player Profiles

7.1 PTM BIO

7.1.1 PTM BIO Company Details

7.1.2 PTM BIO Business Overview

7.1.3 PTM BIO Modified Proteomics Service Introduction

7.1.4 PTM BIO Revenue in Modified Proteomics Service Business (2021-2026)

7.1.5 PTM BIO Recent Development

7.2 Cell Signaling Technology (CST)

7.2.1 Cell Signaling Technology (CST) Company Details

7.2.2 Cell Signaling Technology (CST) Business Overview

7.2.3 Cell Signaling Technology (CST) Modified Proteomics Service Introduction

7.2.4 Cell Signaling Technology (CST) Revenue in Modified Proteomics Service Business (2021-2026)

7.2.5 Cell Signaling Technology (CST) Recent Development

7.3 APTBIO

7.3.1 APTBIO Company Details

7.3.2 APTBIO Business Overview

7.3.3 APTBIO Modified Proteomics Service Introduction

7.3.4 APTBIO Revenue in Modified Proteomics Service Business (2021-2026)

7.3.5 APTBIO Recent Development

7.4 BGI Genomics

7.4.1 BGI Genomics Company Details

7.4.2 BGI Genomics Business Overview

7.4.3 BGI Genomics Modified Proteomics Service Introduction

7.4.4 BGI Genomics Revenue in Modified Proteomics Service Business (2021-2026)

7.4.5 BGI Genomics Recent Development

7.5 OmicScouts (Momentum Biotechnologies)

7.5.1 OmicScouts (Momentum Biotechnologies) Company Details

7.5.2 OmicScouts (Momentum Biotechnologies) Business Overview

7.5.3 OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Introduction

7.5.4 OmicScouts (Momentum Biotechnologies) Revenue in Modified Proteomics Service Business (2021-2026)

7.5.5 OmicScouts (Momentum Biotechnologies) Recent Development

7.6 Biodesix

7.6.1 Biodesix Company Details

7.6.2 Biodesix Business Overview

7.6.3 Biodesix Modified Proteomics Service Introduction

7.6.4 Biodesix Revenue in Modified Proteomics Service Business (2021-2026)

7.6.5 Biodesix Recent Development

7.7 Shanghai OE Biotech

7.7.1 Shanghai OE Biotech Company Details

7.7.2 Shanghai OE Biotech Business Overview

7.7.3 Shanghai OE Biotech Modified Proteomics Service Introduction

7.7.4 Shanghai OE Biotech Revenue in Modified Proteomics Service Business (2021-2026)

7.7.5 Shanghai OE Biotech Recent Development

7.8 Crown Bioscience

7.8.1 Crown Bioscience Company Details

7.8.2 Crown Bioscience Business Overview

7.8.3 Crown Bioscience Modified Proteomics Service Introduction

7.8.4 Crown Bioscience Revenue in Modified Proteomics Service Business (2021-2026)

7.8.5 Crown Bioscience Recent Development

7.9 Shanghai Bioprofile

7.9.1 Shanghai Bioprofile Company Details

7.9.2 Shanghai Bioprofile Business Overview

7.9.3 Shanghai Bioprofile Modified Proteomics Service Introduction

7.9.4 Shanghai Bioprofile Revenue in Modified Proteomics Service Business (2021-2026)

7.9.5 Shanghai Bioprofile Recent Development

7.10 Creative Proteomics

7.10.1 Creative Proteomics Company Details

7.10.2 Creative Proteomics Business Overview

7.10.3 Creative Proteomics Modified Proteomics Service Introduction

7.10.4 Creative Proteomics Revenue in Modified Proteomics Service Business (2021-2026)

7.10.5 Creative Proteomics Recent Development

7.11 Inotiv

7.11.1 Inotiv Company Details

7.11.2 Inotiv Business Overview

7.11.3 Inotiv Modified Proteomics Service Introduction

7.11.4 Inotiv Revenue in Modified Proteomics Service Business (2021-2026)

7.11.5 Inotiv Recent Development

7.12 MtoZ-Biolabs

7.12.1 MtoZ-Biolabs Company Details

7.12.2 MtoZ-Biolabs Business Overview

7.12.3 MtoZ-Biolabs Modified Proteomics Service Introduction

7.12.4 MtoZ-Biolabs Revenue in Modified Proteomics Service Business (2021-2026)

7.12.5 MtoZ-Biolabs Recent Development

7.13 CellCarta

7.13.1 CellCarta Company Details

7.13.2 CellCarta Business Overview

7.13.3 CellCarta Modified Proteomics Service Introduction

7.13.4 CellCarta Revenue in Modified Proteomics Service Business (2021-2026)

7.13.5 CellCarta Recent Development

7.14 Biognosys

7.14.1 Biognosys Company Details

7.14.2 Biognosys Business Overview

7.14.3 Biognosys Modified Proteomics Service Introduction

7.14.4 Biognosys Revenue in Modified Proteomics Service Business (2021-2026)

7.14.5 Biognosys Recent Development

7.15 MS Bioworks

7.15.1 MS Bioworks Company Details

7.15.2 MS Bioworks Business Overview

7.15.3 MS Bioworks Modified Proteomics Service Introduction

7.15.4 MS Bioworks Revenue in Modified Proteomics Service Business (2021-2026)

7.15.5 MS Bioworks Recent Development

7.16 Charles River Laboratories

7.16.1 Charles River Laboratories Company Details

7.16.2 Charles River Laboratories Business Overview

7.16.3 Charles River Laboratories Modified Proteomics Service Introduction

7.16.4 Charles River Laboratories Revenue in Modified Proteomics Service Business (2021-2026)

7.16.5 Charles River Laboratories Recent Development

7.17 Metware Biotechnology

7.17.1 Metware Biotechnology Company Details

7.17.2 Metware Biotechnology Business Overview

7.17.3 Metware Biotechnology Modified Proteomics Service Introduction

7.17.4 Metware Biotechnology Revenue in Modified Proteomics Service Business (2021-2026)

7.17.5 Metware Biotechnology Recent Development

7.18 Novogene

7.18.1 Novogene Company Details

7.18.2 Novogene Business Overview

7.18.3 Novogene Modified Proteomics Service Introduction

7.18.4 Novogene Revenue in Modified Proteomics Service Business (2021-2026)

7.18.5 Novogene Recent Development

7.19 Evotec

7.19.1 Evotec Company Details

7.19.2 Evotec Business Overview

7.19.3 Evotec Modified Proteomics Service Introduction

7.19.4 Evotec Revenue in Modified Proteomics Service Business (2021-2026)

7.19.5 Evotec Recent Development

7.20 RxCelerate

7.20.1 RxCelerate Company Details

7.20.2 RxCelerate Business Overview

7.20.3 RxCelerate Modified Proteomics Service Introduction

7.20.4 RxCelerate Revenue in Modified Proteomics Service Business (2021-2026)

7.20.5 RxCelerate Recent Development

7.21 Shanghai Majorbio Bio-Pharm

7.21.1 Shanghai Majorbio Bio-Pharm Company Details

7.21.2 Shanghai Majorbio Bio-Pharm Business Overview

7.21.3 Shanghai Majorbio Bio-Pharm Modified Proteomics Service Introduction

7.21.4 Shanghai Majorbio Bio-Pharm Revenue in Modified Proteomics Service Business (2021-2026)

7.21.5 Shanghai Majorbio Bio-Pharm Recent Development

7.22 Lc-Bio Technologies

7.22.1 Lc-Bio Technologies Company Details

7.22.2 Lc-Bio Technologies Business Overview

7.22.3 Lc-Bio Technologies Modified Proteomics Service Introduction

7.22.4 Lc-Bio Technologies Revenue in Modified Proteomics Service Business (2021-2026)

7.22.5 Lc-Bio Technologies Recent Development

7.23 CD Genomics

7.23.1 CD Genomics Company Details

7.23.2 CD Genomics Business Overview

7.23.3 CD Genomics Modified Proteomics Service Introduction

7.23.4 CD Genomics Revenue in Modified Proteomics Service Business (2021-2026)

7.23.5 CD Genomics Recent Development

7.24 Discovery Life Sciences

7.24.1 Discovery Life Sciences Company Details

7.24.2 Discovery Life Sciences Business Overview

7.24.3 Discovery Life Sciences Modified Proteomics Service Introduction

7.24.4 Discovery Life Sciences Revenue in Modified Proteomics Service Business (2021-2026)

7.24.5 Discovery Life Sciences Recent Development

7.25 Applied Biomics

7.25.1 Applied Biomics Company Details

7.25.2 Applied Biomics Business Overview

7.25.3 Applied Biomics Modified Proteomics Service Introduction

7.25.4 Applied Biomics Revenue in Modified Proteomics Service Business (2021-2026)

7.25.5 Applied Biomics Recent Development

7.26 VProteomics

7.26.1 VProteomics Company Details

7.26.2 VProteomics Business Overview

7.26.3 VProteomics Modified Proteomics Service Introduction

7.26.4 VProteomics Revenue in Modified Proteomics Service Business (2021-2026)

7.26.5 VProteomics Recent Development

7.27 Allumiqs

7.27.1 Allumiqs Company Details

7.27.2 Allumiqs Business Overview

7.27.3 Allumiqs Modified Proteomics Service Introduction

7.27.4 Allumiqs Revenue in Modified Proteomics Service Business (2021-2026)

7.27.5 Allumiqs Recent Development

7.28 Westlake Omics

7.28.1 Westlake Omics Company Details

7.28.2 Westlake Omics Business Overview

7.28.3 Westlake Omics Modified Proteomics Service Introduction

7.28.4 Westlake Omics Revenue in Modified Proteomics Service Business (2021-2026)

7.28.5 Westlake Omics Recent Development

7.29 CDI Labs

7.29.1 CDI Labs Company Details

7.29.2 CDI Labs Business Overview

7.29.3 CDI Labs Modified Proteomics Service Introduction

7.29.4 CDI Labs Revenue in Modified Proteomics Service Business (2021-2026)

7.29.5 CDI Labs Recent Development

7.30 Proteome Sciences

7.30.1 Proteome Sciences Company Details

7.30.2 Proteome Sciences Business Overview

7.30.3 Proteome Sciences Modified Proteomics Service Introduction

7.30.4 Proteome Sciences Revenue in Modified Proteomics Service Business (2021-2026)

7.30.5 Proteome Sciences Recent Development

7.31 Sapient Bioanalytics

7.31.1 Sapient Bioanalytics Company Details

7.31.2 Sapient Bioanalytics Business Overview

7.31.3 Sapient Bioanalytics Modified Proteomics Service Introduction

7.31.4 Sapient Bioanalytics Revenue in Modified Proteomics Service Business (2021-2026)

7.31.5 Sapient Bioanalytics Recent Development

7.32 Proteomics International

7.32.1 Proteomics International Company Details

7.32.2 Proteomics International Business Overview

7.32.3 Proteomics International Modified Proteomics Service Introduction

7.32.4 Proteomics International Revenue in Modified Proteomics Service Business (2021-2026)

7.32.5 Proteomics International Recent Development

7.33 Cosmos Wisdom

7.33.1 Cosmos Wisdom Company Details

7.33.2 Cosmos Wisdom Business Overview

7.33.3 Cosmos Wisdom Modified Proteomics Service Introduction

7.33.4 Cosmos Wisdom Revenue in Modified Proteomics Service Business (2021-2026)

7.33.5 Cosmos Wisdom Recent Development

7.34 MRM Proteomics

7.34.1 MRM Proteomics Company Details

7.34.2 MRM Proteomics Business Overview

7.34.3 MRM Proteomics Modified Proteomics Service Introduction

7.34.4 MRM Proteomics Revenue in Modified Proteomics Service Business (2021-2026)

7.34.5 MRM Proteomics Recent Development

7.35 Sinotech Genomics

7.35.1 Sinotech Genomics Company Details

7.35.2 Sinotech Genomics Business Overview

7.35.3 Sinotech Genomics Modified Proteomics Service Introduction

7.35.4 Sinotech Genomics Revenue in Modified Proteomics Service Business (2021-2026)

7.35.5 Sinotech Genomics Recent Development

7.36 Precision Biomarker Laboratories (PBL)

7.36.1 Precision Biomarker Laboratories (PBL) Company Details

7.36.2 Precision Biomarker Laboratories (PBL) Business Overview

7.36.3 Precision Biomarker Laboratories (PBL) Modified Proteomics Service Introduction

7.36.4 Precision Biomarker Laboratories (PBL) Revenue in Modified Proteomics Service Business (2021-2026)

7.36.5 Precision Biomarker Laboratories (PBL) Recent Development

8 Modified Proteomics Service Market Dynamics

8.1 Modified Proteomics Service Industry Trends

8.2 Modified Proteomics Service Market Drivers

8.3 Modified Proteomics Service Market Challenges

8.4 Modified Proteomics Service Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Modified Proteomics Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Modified Proteomics Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Modified Proteomics Service Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Modified Proteomics Service Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Modified Proteomics Service Revenue Share by Region (2021-2026)

Table 6. Global Modified Proteomics Service Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Modified Proteomics Service Revenue Share Forecast by Region (2027-2032)

Table 8. Global Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Modified Proteomics Service Market Share by Revenue, by Type (2021-2026)

Table 10. Global Modified Proteomics Service Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Modified Proteomics Service Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Modified Proteomics Service Market Share by Revenue, by Application (2021-2026)

Table 15. Global Modified Proteomics Service Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Modified Proteomics Service Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Modified Proteomics Service Applications

Table 18. Global Modified Proteomics Service Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Modified Proteomics Service Market Share by Players (2021-2026)

Table 20. Global Top Modified Proteomics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modified Proteomics Service as of 2025)

Table 21. Ranking of Global Top Modified Proteomics Service Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Modified Proteomics Service Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Modified Proteomics Service, Headquarters and Area Served

Table 24. Global Key Players of Modified Proteomics Service, Product and Application

Table 25. Global Key Players of Modified Proteomics Service, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Modified Proteomics Service Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Modified Proteomics Service Market Share by Revenue, by Company (2021-2026)

Table 29. North America Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Modified Proteomics Service Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Modified Proteomics Service Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million)

Table 35. China Modified Proteomics Service Revenue by Company (2021-2026) & (US$ Million)

Table 36. China Modified Proteomics Service Market Share by Revenue, by Company (2021-2026)

Table 37. China Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million)

Table 38. China Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million)

Table 39. Japan Modified Proteomics Service Revenue by Company (2021-2026) & (US$ Million)

Table 40. Japan Modified Proteomics Service Market Share by Revenue, by Company (2021-2026)

Table 41. Japan Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million)

Table 42. Japan Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million)

Table 43. Southeast Asia Modified Proteomics Service Revenue by Company (2021-2026) & (US$ Million)

Table 44. Southeast Asia Modified Proteomics Service Market Share by Revenue, by Company (2021-2026)

Table 45. Southeast Asia Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million)

Table 46. Southeast Asia Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million)

Table 47. India Modified Proteomics Service Revenue by Company (2021-2026) & (US$ Million)

Table 48. India Modified Proteomics Service Market Share by Revenue, by Company (2021-2026)

Table 49. India Modified Proteomics Service Market Size by Type (2021-2026) & (US$ Million)

Table 50. India Modified Proteomics Service Market Size by Application (2021-2026) & (US$ Million)

Table 51. PTM BIO Company Details

Table 52. PTM BIO Business Overview

Table 53. PTM BIO Modified Proteomics Service Product

Table 54. PTM BIO Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 55. PTM BIO Recent Development

Table 56. Cell Signaling Technology (CST) Company Details

Table 57. Cell Signaling Technology (CST) Business Overview

Table 58. Cell Signaling Technology (CST) Modified Proteomics Service Product

Table 59. Cell Signaling Technology (CST) Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 60. Cell Signaling Technology (CST) Recent Development

Table 61. APTBIO Company Details

Table 62. APTBIO Business Overview

Table 63. APTBIO Modified Proteomics Service Product

Table 64. APTBIO Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 65. APTBIO Recent Development

Table 66. BGI Genomics Company Details

Table 67. BGI Genomics Business Overview

Table 68. BGI Genomics Modified Proteomics Service Product

Table 69. BGI Genomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 70. BGI Genomics Recent Development

Table 71. OmicScouts (Momentum Biotechnologies) Company Details

Table 72. OmicScouts (Momentum Biotechnologies) Business Overview

Table 73. OmicScouts (Momentum Biotechnologies) Modified Proteomics Service Product

Table 74. OmicScouts (Momentum Biotechnologies) Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 75. OmicScouts (Momentum Biotechnologies) Recent Development

Table 76. Biodesix Company Details

Table 77. Biodesix Business Overview

Table 78. Biodesix Modified Proteomics Service Product

Table 79. Biodesix Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 80. Biodesix Recent Development

Table 81. Shanghai OE Biotech Company Details

Table 82. Shanghai OE Biotech Business Overview

Table 83. Shanghai OE Biotech Modified Proteomics Service Product

Table 84. Shanghai OE Biotech Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 85. Shanghai OE Biotech Recent Development

Table 86. Crown Bioscience Company Details

Table 87. Crown Bioscience Business Overview

Table 88. Crown Bioscience Modified Proteomics Service Product

Table 89. Crown Bioscience Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 90. Crown Bioscience Recent Development

Table 91. Shanghai Bioprofile Company Details

Table 92. Shanghai Bioprofile Business Overview

Table 93. Shanghai Bioprofile Modified Proteomics Service Product

Table 94. Shanghai Bioprofile Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 95. Shanghai Bioprofile Recent Development

Table 96. Creative Proteomics Company Details

Table 97. Creative Proteomics Business Overview

Table 98. Creative Proteomics Modified Proteomics Service Product

Table 99. Creative Proteomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 100. Creative Proteomics Recent Development

Table 101. Inotiv Company Details

Table 102. Inotiv Business Overview

Table 103. Inotiv Modified Proteomics Service Product

Table 104. Inotiv Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 105. Inotiv Recent Development

Table 106. MtoZ-Biolabs Company Details

Table 107. MtoZ-Biolabs Business Overview

Table 108. MtoZ-Biolabs Modified Proteomics Service Product

Table 109. MtoZ-Biolabs Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 110. MtoZ-Biolabs Recent Development

Table 111. CellCarta Company Details

Table 112. CellCarta Business Overview

Table 113. CellCarta Modified Proteomics Service Product

Table 114. CellCarta Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 115. CellCarta Recent Development

Table 116. Biognosys Company Details

Table 117. Biognosys Business Overview

Table 118. Biognosys Modified Proteomics Service Product

Table 119. Biognosys Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 120. Biognosys Recent Development

Table 121. MS Bioworks Company Details

Table 122. MS Bioworks Business Overview

Table 123. MS Bioworks Modified Proteomics Service Product

Table 124. MS Bioworks Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 125. MS Bioworks Recent Development

Table 126. Charles River Laboratories Company Details

Table 127. Charles River Laboratories Business Overview

Table 128. Charles River Laboratories Modified Proteomics Service Product

Table 129. Charles River Laboratories Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 130. Charles River Laboratories Recent Development

Table 131. Metware Biotechnology Company Details

Table 132. Metware Biotechnology Business Overview

Table 133. Metware Biotechnology Modified Proteomics Service Product

Table 134. Metware Biotechnology Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 135. Metware Biotechnology Recent Development

Table 136. Novogene Company Details

Table 137. Novogene Business Overview

Table 138. Novogene Modified Proteomics Service Product

Table 139. Novogene Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 140. Novogene Recent Development

Table 141. Evotec Company Details

Table 142. Evotec Business Overview

Table 143. Evotec Modified Proteomics Service Product

Table 144. Evotec Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 145. Evotec Recent Development

Table 146. RxCelerate Company Details

Table 147. RxCelerate Business Overview

Table 148. RxCelerate Modified Proteomics Service Product

Table 149. RxCelerate Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 150. RxCelerate Recent Development

Table 151. Shanghai Majorbio Bio-Pharm Company Details

Table 152. Shanghai Majorbio Bio-Pharm Business Overview

Table 153. Shanghai Majorbio Bio-Pharm Modified Proteomics Service Product

Table 154. Shanghai Majorbio Bio-Pharm Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 155. Shanghai Majorbio Bio-Pharm Recent Development

Table 156. Lc-Bio Technologies Company Details

Table 157. Lc-Bio Technologies Business Overview

Table 158. Lc-Bio Technologies Modified Proteomics Service Product

Table 159. Lc-Bio Technologies Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 160. Lc-Bio Technologies Recent Development

Table 161. CD Genomics Company Details

Table 162. CD Genomics Business Overview

Table 163. CD Genomics Modified Proteomics Service Product

Table 164. CD Genomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 165. CD Genomics Recent Development

Table 166. Discovery Life Sciences Company Details

Table 167. Discovery Life Sciences Business Overview

Table 168. Discovery Life Sciences Modified Proteomics Service Product

Table 169. Discovery Life Sciences Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 170. Discovery Life Sciences Recent Development

Table 171. Applied Biomics Company Details

Table 172. Applied Biomics Business Overview

Table 173. Applied Biomics Modified Proteomics Service Product

Table 174. Applied Biomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 175. Applied Biomics Recent Development

Table 176. VProteomics Company Details

Table 177. VProteomics Business Overview

Table 178. VProteomics Modified Proteomics Service Product

Table 179. VProteomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 180. VProteomics Recent Development

Table 181. Allumiqs Company Details

Table 182. Allumiqs Business Overview

Table 183. Allumiqs Modified Proteomics Service Product

Table 184. Allumiqs Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 185. Allumiqs Recent Development

Table 186. Westlake Omics Company Details

Table 187. Westlake Omics Business Overview

Table 188. Westlake Omics Modified Proteomics Service Product

Table 189. Westlake Omics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 190. Westlake Omics Recent Development

Table 191. CDI Labs Company Details

Table 192. CDI Labs Business Overview

Table 193. CDI Labs Modified Proteomics Service Product

Table 194. CDI Labs Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 195. CDI Labs Recent Development

Table 196. Proteome Sciences Company Details

Table 197. Proteome Sciences Business Overview

Table 198. Proteome Sciences Modified Proteomics Service Product

Table 199. Proteome Sciences Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 200. Proteome Sciences Recent Development

Table 201. Sapient Bioanalytics Company Details

Table 202. Sapient Bioanalytics Business Overview

Table 203. Sapient Bioanalytics Modified Proteomics Service Product

Table 204. Sapient Bioanalytics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 205. Sapient Bioanalytics Recent Development

Table 206. Proteomics International Company Details

Table 207. Proteomics International Business Overview

Table 208. Proteomics International Modified Proteomics Service Product

Table 209. Proteomics International Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 210. Proteomics International Recent Development

Table 211. Cosmos Wisdom Company Details

Table 212. Cosmos Wisdom Business Overview

Table 213. Cosmos Wisdom Modified Proteomics Service Product

Table 214. Cosmos Wisdom Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 215. Cosmos Wisdom Recent Development

Table 216. MRM Proteomics Company Details

Table 217. MRM Proteomics Business Overview

Table 218. MRM Proteomics Modified Proteomics Service Product

Table 219. MRM Proteomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 220. MRM Proteomics Recent Development

Table 221. Sinotech Genomics Company Details

Table 222. Sinotech Genomics Business Overview

Table 223. Sinotech Genomics Modified Proteomics Service Product

Table 224. Sinotech Genomics Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 225. Sinotech Genomics Recent Development

Table 226. Precision Biomarker Laboratories (PBL) Company Details

Table 227. Precision Biomarker Laboratories (PBL) Business Overview

Table 228. Precision Biomarker Laboratories (PBL) Modified Proteomics Service Product

Table 229. Precision Biomarker Laboratories (PBL) Revenue in Modified Proteomics Service Business (2021-2026) & (US$ Million)

Table 230. Precision Biomarker Laboratories (PBL) Recent Development

Table 231. Modified Proteomics Service Market Trends

Table 232. Modified Proteomics Service Market Drivers

Table 233. Modified Proteomics Service Market Challenges

Table 234. Modified Proteomics Service Market Restraints

Table 235. Research Programs/Design for This Report

Table 236. Key Data Information from Secondary Sources

Table 237. Key Data Information from Primary Sources

List of Figures

Figure 1. Modified Proteomics Service Product Picture

Figure 2. Global Modified Proteomics Service Market Share by Type: 2025 vs 2032

Figure 3. Phosphorylation Features

Figure 4. Acetylation Features

Figure 5. Ubiquitination Features

Figure 6. Methylation Features

Figure 7. Glycosylation Features

Figure 8. Lactylation Features

Figure 9. Redox Features

Figure 10. Palmitoylation Features

Figure 11. Others Features

Figure 12. Global Modified Proteomics Service Market Share by Application: 2025 vs 2032

Figure 13. Clinical Diagnostics

Figure 14. Drug Discovery

Figure 15. Others

Figure 16. Modified Proteomics Service Report Years Considered

Figure 17. Global Modified Proteomics Service Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 18. Global Modified Proteomics Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Modified Proteomics Service Market Share by Revenue, by Region: 2021 vs 2025

Figure 20. North America Modified Proteomics Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 21. Europe Modified Proteomics Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 22. China Modified Proteomics Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 23. Japan Modified Proteomics Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 24. Southeast Asia Modified Proteomics Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 25. India Modified Proteomics Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 26. South America Modified Proteomics Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 27. Middle East Modified Proteomics Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 28. Global Modified Proteomics Service Market Share by Players in 2025

Figure 29. Global Top Modified Proteomics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modified Proteomics Service as of 2025)

Figure 30. The Top 10 and 5 Players Market Share by Modified Proteomics Service Revenue in 2025

Figure 31. North America Modified Proteomics Service Market Share by Type (2021-2026)

Figure 32. North America Modified Proteomics Service Market Share by Application (2021-2026)

Figure 33. Europe Modified Proteomics Service Market Share by Type (2021-2026)

Figure 34. Europe Modified Proteomics Service Market Share by Application (2021-2026)

Figure 35. China Modified Proteomics Service Market Share by Type (2021-2026)

Figure 36. China Modified Proteomics Service Market Share by Application (2021-2026)

Figure 37. Japan Modified Proteomics Service Market Share by Type (2021-2026)

Figure 38. Japan Modified Proteomics Service Market Share by Application (2021-2026)

Figure 39. Southeast Asia Modified Proteomics Service Market Share by Type (2021-2026)

Figure 40. Southeast Asia Modified Proteomics Service Market Share by Application (2021-2026)

Figure 41. India Modified Proteomics Service Market Share by Type (2021-2026)

Figure 42. India Modified Proteomics Service Market Share by Application (2021-2026)

Figure 43. PTM BIO Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 44. Cell Signaling Technology (CST) Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 45. APTBIO Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 46. BGI Genomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 47. OmicScouts (Momentum Biotechnologies) Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 48. Biodesix Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 49. Shanghai OE Biotech Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 50. Crown Bioscience Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 51. Shanghai Bioprofile Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 52. Creative Proteomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 53. Inotiv Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 54. MtoZ-Biolabs Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 55. CellCarta Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 56. Biognosys Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 57. MS Bioworks Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 58. Charles River Laboratories Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 59. Metware Biotechnology Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 60. Novogene Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 61. Evotec Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 62. RxCelerate Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 63. Shanghai Majorbio Bio-Pharm Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 64. Lc-Bio Technologies Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 65. CD Genomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 66. Discovery Life Sciences Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 67. Applied Biomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 68. VProteomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 69. Allumiqs Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 70. Westlake Omics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 71. CDI Labs Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 72. Proteome Sciences Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 73. Sapient Bioanalytics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 74. Proteomics International Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 75. Cosmos Wisdom Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 76. MRM Proteomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 77. Sinotech Genomics Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 78. Precision Biomarker Laboratories (PBL) Revenue Growth Rate in Modified Proteomics Service Business (2021-2026)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Modified Proteomics Service in 2026? zhanKai

The global market size of Modified Proteomics Service in 2026 was 915 Million USD.

Which companies rank high in the global Modified Proteomics Service market? shouQi

What is the annual compound growth rate of the global Modified Proteomics Service market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Modified Proteomics Service in 2032? shouQi

Related Reports

Modified Proteomics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Modified Proteomics Service was estimated to be worth US$ 854 million in 2025 and is projected to reach US$ 1554 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 182
USD 3950.00
(Single User License)
Global Modified Proteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Modified Proteomics Service market is projected to grow from US$ 854 million in 2025 to US$ 1554 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-17
Pages: 194
USD 4900.00
(Single User License)
Global Modified Proteomics Service Market Research Report 2026
The global Modified Proteomics Service market was valued at US$ 854 million in 2025 and is anticipated to reach US$ 1554 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 209
USD 2900.00
(Single User License)

Modified Proteomics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Modified Proteomics Service was estimated to be worth US$ 854 million in 2025 and is projected to reach US$ 1554 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-07-17
Pages: 182
USD 3950.00 (Single User License)
Global Modified Proteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Modified Proteomics Service market is projected to grow from US$ 854 million in 2025 to US$ 1554 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-17
Pages: 194
USD 4900.00 (Single User License)
Global Modified Proteomics Service Market Research Report 2026
The global Modified Proteomics Service market was valued at US$ 854 million in 2025 and is anticipated to reach US$ 1554 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-07-17
Pages: 209
USD 2900.00 (Single User License)